ImmunityBio, Inc. Q1 FY2026 Earnings Call

ImmunityBio, Inc. (IBRX)

Earnings Call FY2026 Q1 Call date: 2026-05-07 Concluded

Quarter scorecard

Revenue

$44.21M

+167.6% YoY

Diluted EPS

$-0.62

Net income

-$632.78M

Product $44.17M

+167.5%

Product And Service Other $39,000

+387.5%